Gamida Cell Stock Shares Owned By Insiders
| GMDADelisted Stock | USD 1.40 0.09 6.04% |
Gamida Cell fundamentals help investors to digest information that contributes to Gamida Cell's financial success or failures. It also enables traders to predict the movement of Gamida Stock. The fundamental analysis module provides a way to measure Gamida Cell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gamida Cell stock.
Gamida |
Gamida Cell Company Shares Owned By Insiders Analysis
Gamida Cell's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Gamida Cell Shares Owned By Insiders | 11.57 % |
Most of Gamida Cell's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gamida Cell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 11.57% of Gamida Cell are shares owned by insiders. This is 23.78% lower than that of the Biotechnology sector and 18.41% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 14.67% lower than that of the firm.
Gamida Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gamida Cell's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gamida Cell could also be used in its relative valuation, which is a method of valuing Gamida Cell by comparing valuation metrics of similar companies.Gamida Cell is currently under evaluation in shares owned by insiders category among its peers.
Gamida Fundamentals
| Return On Equity | -11.04 | |||
| Return On Asset | -0.41 | |||
| Operating Margin | (26.80) % | |||
| Current Valuation | 70.28 M | |||
| Shares Outstanding | 132.64 M | |||
| Shares Owned By Insiders | 11.57 % | |||
| Shares Owned By Institutions | 26.48 % | |||
| Number Of Shares Shorted | 10.96 M | |||
| Price To Earning | (3.97) X | |||
| Price To Book | 117.40 X | |||
| Price To Sales | 6.44 X | |||
| Revenue | 1.78 M | |||
| EBITDA | (70.62 M) | |||
| Net Income | (63 M) | |||
| Cash And Equivalents | 55.06 M | |||
| Cash Per Share | 0.92 X | |||
| Total Debt | 82.94 M | |||
| Current Ratio | 2.57 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (79.12 M) | |||
| Short Ratio | 3.51 X | |||
| Earnings Per Share | (0.82) X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 143 | |||
| Beta | 1.03 | |||
| Market Capitalization | 4.34 M | |||
| Total Asset | 102.19 M | |||
| Retained Earnings | (479.83 M) | |||
| Working Capital | 29.34 M | |||
| Current Asset | 56.03 M | |||
| Current Liabilities | 9.55 M | |||
| Net Asset | 102.19 M |
About Gamida Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gamida Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gamida Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gamida Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Gamida Stock
If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |